Evidence map›Paper›PMID 24936146›Full record

ArticleInternational journal of medical sciences2014

Frequent co-expression of miRNA-5p and -3p species and cross-targeting in induced pluripotent stem cells.

Chiu-Jung Huang, Phan Nguyen Nhi Nguyen, Kong Bung Choo, Shigeki Sugii, Kenneth Wee, Soon Keng Cheong, Tunku Kamarul

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Chiu-Jung Huang1. Department of Animal Science & Graduate Institute of Biotechnology, Chinese Culture University, Taipei, Taiwan;
Phan Nguyen Nhi Nguyen2. Centre for Stem Cell Research, Universiti Tunku Abdul Rahman, Faculty of Medicine and Health Sciences, Kajang, Selangor, Malaysia;
Kong Bung Choo2. Centre for Stem Cell Research, Universiti Tunku Abdul Rahman, Faculty of Medicine and Health Sciences, Kajang, Selangor, Malaysia; ; 3. Department of Preclinical Sciences, Universiti Tunku Abdul Rahman, Faculty of Medicine and Health Sciences, Kajang, Selangor, Malaysia;
Shigeki Sugii4. Singapore BioImaging Consortium, Singapore; ; 5. Duke-NUS Graduate Medical School, Singapore;
Kenneth Wee4. Singapore BioImaging Consortium, Singapore;
Soon Keng Cheong2. Centre for Stem Cell Research, Universiti Tunku Abdul Rahman, Faculty of Medicine and Health Sciences, Kajang, Selangor, Malaysia; ; 6. Dean's Office, Universiti Tunku Abdul Rahman, Faculty of Medicine and Health Sciences, Kajang, Selangor, Malaysia;
Tunku Kamarul7. Tissue Engineering Group, National Orthopaedic Centre of Excellence for Research and Learning, Department of Orthopaedic Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Duke-NUS Medical School · SGUniversiti Tunku Abdul Rahman · MYChinese Culture University · TWOrthopaedic Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA miRNA precursor generally gives rise to one major miRNA species derived from the 5' arm, and are called miRNA-5p. However, more recent studies have shown co-expression of miRNA-5p and -3p, albeit in different concentrations, in cancer cells targeting different sets of transcripts. Co-expression and regulation of the -5p and -3p miRNA species in stem cells, particularly in the reprogramming process, have not been studied.

methodsIn this work, we investigated co-expression and regulation of miRNA-5p and -3p species in human induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs) and embryonic stem cells (ESC) using a nanoliter-scale real-time PCR microarray platform that included 1,036 miRNAs.

resultsIn comparing iPSC and ESC, only 32 miRNAs were found to be differentially expressed, in agreement of the ESC-like nature of iPSC. In the analysis of reprogramming process in iPSCs, 261 miRNAs were found to be differentially expressed compared with the parental MSC and pre-adipose tissue, indicating significant miRNA alternations in the reprogramming process. In iPSC reprogrammed from MSC, there were 88 miRNAs (33.7%), or 44 co-expressed 5p/3p pairs, clearly indicating frequent co-expression of both miRNA species on reprogramming. Of these, 40 pairs were either co-up- or co-downregulated indicating concerted 5p/3p regulation. The 5p/3p species of only 4 pairs were regulated in reverse directions. Furthermore, some 5p/3p species of the same miRNAs were found to target the same transcript and the same miRNA may cross-target different transcripts of proteins of the G1/S transition of the cell cycle; 5p/3p co-targeting was confirmed in stem-loop RT-PCR.

conclusionThe observed cross- and co-regulation by paired miRNA species suggests a fail-proof scheme of miRNA regulation in iPSC, which may be important to iPSC pluripotency.

Indexed as

Cell DifferentiationCellular ReprogrammingEmbryonic Stem CellsGene Expression Regulation, DevelopmentalHumansInduced Pluripotent Stem CellsMesenchymal Stem CellsMicroRNAsMicroRNAscell cycle controlInduced pluripotent stem cellsmiRNA-5p/3p speciesreprogramming

Identifiers

PMID24936146
PMCPMC4057479
OpenAlexW2153857245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.